Zentek Ltd. provided a strategic and regulatory update outlining a tighter focus on its core platforms: Albany Graphite, ZenGUARD and Triera, alongside plans to reduce its cost base, pause or wind down non-core initiatives, and link future capital raises to specific milestones. The company reported independent laboratory testing showing Albany graphite can be purified to 5N (99.9992%) with an equivalent boron concentration of 2.60 ppm, meeting a sub-3 ppm threshold cited for nuclear applications, using a halogen-free purification process. Near-term Albany steps include updating the project’s Preliminary Economic Assessment, expanding pilot-scale processing to generate samples representative of commercial production, and advancing environmental and social baseline work with Constance Lake First Nation and local communities, with an objective over the next 12 to 18 months to position the project for a potential spin-out, strategic partnership or other value-realization structure. On the regulatory front, Zentek said Health Canada’s current position is that ZenGUARD Enhanced Air Filters are pest control products under the Pest Control Products Act and do not qualify as a medical device under the Food and Drugs Act. The company stated it has been engaging with Health Canada’s Pest Management Regulatory Agency since Dec. 1, 2025, including a submission on Feb. 5, 2026, providing experimental protocols, third-party laboratory reports and mechanical air flow reports, and noted that if Health Canada’s determination remains unchanged, commercialization in Canada could require additional cost and time.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentek Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-001170), on February 26, 2026, and is solely responsible for the information contained therein.
Comments